(Q30375714)

21 June 2017

1 reference

title

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. (English)

1 reference

21 June 2017

0 references

1 reference

1 reference

Lorena E Brown

1

0 references

Anne Kelso

object named as

Anne Kelso

series ordinal

2

0 references

publication date

24 March 2009

1 reference

Immunology & Cell Biology

21 June 2017

1 reference

21 June 2017

87

1 reference

21 June 2017

300-308

1 reference

21 June 2017

4

1 reference

Estimating influenza vaccine efficacy from challenge and community-based study data

21 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cytotoxic T cells in influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Molecular mechanisms of variation in influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Modified M2 proteins produce heterotypic immunity against influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-gamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cytotoxic T-cell immunity to influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Declining T-cell immunity to influenza, 1977-82

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Influenza A virus specific T cell immunity in humans during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Disquisitions of Original Antigenic Sin. I. Evidence in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A global pandemic influenza vaccine action plan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Ecological and immunological determinants of influenza evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

HLA class I supertypes: a revised and updated classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

21 January 2018

A new look at T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Bone marrow-derived cells expand memory CD8+ T cells in response to viral infections of the lung and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Differential response of respiratory dendritic cell subsets to influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Current status of live attenuated influenza virus vaccine in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Influenza vaccines: the virosome concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Regulation of interferon-gamma during innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

The activated type 1-polarized CD8(+) T cell population isolated from an effector site contains cells with flexible cytokine profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Signals required for programming effector and memory development by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Effector and memory CTL differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Recognition of single-stranded RNA viruses by Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

New horizons in adjuvants for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

A mechanism for the initiation of allergen-induced T helper type 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Linear differentiation of cytotoxic effectors into memory T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Virus-specific CD8+ T-cell memory determined by clonal burst size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Shaping and reshaping CD8+ T-cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Generation of CD8 T cell memory is regulated by IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Persistence of memory CD8 T cells in MHC class I-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Antibody responses after inactivated influenza vaccine in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

T cell responses are better correlates of vaccine protection in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.16

7 January 2021

Identifiers

DOI

10.1038/ICB.2009.16

1 reference

21 June 2017

1 reference

PubMed ID

19308073